About BTBP

About BTBP

As a specialized company for blood products under Sinopharm and a "World-Class Professional Leading Demonstration Enterprise" nominated by the State-owned Assets Supervision and Administration Commission.
 Sinopharm Wuhan Biopharmaceuticals Co., Ltd

Wuhan Plasma was originated from the biopharmaceutical business of Wuhan Institute of Biological Products Co., Ltd. It owns an advanced plasma protein separation workshop and was one of the firsts in China to pass the 2010 version of GMP certification. It has established an effective quality assurance system and was recognized as a high-tech enterprise in 2018. In 2023, it was renamed as " Sinopharm Wuhan Biopharmaceuticals Co., Ltd".

Wuhan Plasma always takes quality as the lifeline of the enterprise. It has established a comprehensive management system to continuously improve the products quality. In 2018, Wuhan Plasma was awarded the title of "Little Giant" in Wuhan's science and technology industry; In 2021, it successfully passed the recognition of the "Hubei Enterprise Technology Center" and the "Little Giant" of Hubei Province, and was awarded the honorary title of "Labor Medal" by the Hubei Federation of Trade Unions.


Snapshots